Textile · Founded 1919 · www.kesocorp.com · BSE 502937 · NSE KESORAM IND · ISIN INE087A01019
No Notes Added Yet
1. Business Overview
Kesoram Industries Ltd., post the demerger of its cement business into UltraTech Cement (effective February 2024), is primarily engaged in the manufacturing and sale of Viscose Rayon Filament Yarn (VRFY), Cellulose Transparent Paper (CTP), and chemicals such as Sulphuric Acid and Carbon Disulphide. VRFY is a man-made cellulosic fiber used in various textile applications. CTP is a biodegradable, transparent packaging film. The chemicals produced are used both for captive consumption in VRFY manufacturing and sold to other industrial customers. The company generates revenue from the sale of these manufactured products.
2. Key Segments / Revenue Mix
The company's core segments are:
Viscose Rayon Filament Yarn (VRFY): A key product in the textile industry, valued for its soft texture, drape, and biodegradability.
Cellulose Transparent Paper (CTP): A niche, biodegradable, and eco-friendly packaging material.
Chemicals: Primarily Sulphuric Acid and Carbon Disulphide, used significantly for captive consumption in VRFY production and also sold commercially.
Detailed segment-wise revenue contribution for the current structure (post cement demerger) is not yet readily available in public documents covering a full year of operations. However, these three product lines now constitute the entirety of its industrial operations.
3. Industry & Positioning
VRFY Industry: Kesoram operates in the man-made cellulosic fiber industry, specifically VRFY, which competes with other natural and synthetic fibers. VRFY is positioned as a premium, biodegradable option. Kesoram is one of the established players in India for VRFY, facing competition from domestic manufacturers and international imports.
CTP Industry: The Cellulose Transparent Paper market is a niche segment within the broader packaging industry. It competes with plastic films by offering an eco-friendly, biodegradable alternative, primarily catering to specific packaging needs where transparency and sustainability are valued.
Positioning: Kesoram leverages its long-standing manufacturing expertise and established presence in these specific product categories, catering to premium textile segments with VRFY and eco-conscious packaging needs with CTP.
4. Competitive Advantage (Moat)
Established Operations & Experience: Decades of operational experience in manufacturing VRFY and CTP provide Kesoram with technical know-how, established processes, and quality control capabilities.
Niche Market Focus: Its specialized focus on VRFY (a premium cellulosic fiber) and CTP (biodegradable packaging) allows it to cater to specific market demands that value sustainability and particular product characteristics.
Partial Backward Integration: Manufacturing some key chemical inputs (like sulphuric acid and carbon disulphide) can offer some degree of cost control and supply security, reducing complete reliance on external chemical suppliers.
5. Growth Drivers
Increasing Demand for Sustainable Products: Growing environmental awareness and consumer preference for eco-friendly alternatives are likely to drive demand for biodegradable VRFY (in textiles) and CTP (in packaging).
Textile Market Growth: Overall growth in the Indian textile industry, particularly in segments favoring premium, soft-feel, and sustainable fibers, can boost VRFY sales.
Efficiency & Modernization: Potential for operational improvements, capacity optimization, or technological upgrades in its existing plants to enhance efficiency and product quality.
Expansion into New Applications: Exploring new industrial or consumer applications for VRFY and CTP could open up additional revenue streams.
6. Risks
Raw Material Price Volatility: Key raw materials such as wood pulp (for VRFY and CTP) and other chemicals are subject to global price fluctuations, which can significantly impact production costs and profit margins.
Intense Competition: The textile fiber and packaging markets are competitive, with pressure from larger domestic and international players offering synthetic alternatives or cheaper imports.
Regulatory Environment: The chemical and manufacturing industries are subject to evolving environmental norms and regulations, which could lead to increased compliance costs and operational restrictions.
Economic Cyclicality: Demand for textiles and certain packaging materials can be sensitive to economic downturns, impacting sales volumes and pricing.
Small Scale of Operations: Post-demerger, Kesoram is a significantly smaller entity, which might limit its resilience to economic shocks or its ability to invest heavily in large-scale expansions.
7. Management & Ownership
Kesoram Industries Ltd. is promoted by the B.K. Birla Group. Following the demise of Basant Kumar Birla, Kumar Mangalam Birla, Chairman of the Aditya Birla Group, has taken an increasingly active role in the strategic oversight of Kesoram. The recent strategic demerger of the cement business demonstrates a clear move towards streamlining operations and strengthening the balance sheet under this strategic guidance. Promoters hold a significant stake, around 48.74% as of March 2024, with the remaining shares held by institutional investors and the public.
8. Outlook
Kesoram Industries has undergone a significant transformation with the demerger of its cement business, resulting in a more focused company centered on its Viscose Rayon Filament Yarn, Cellulose Transparent Paper, and chemicals operations. This restructuring has considerably reduced its substantial debt burden, providing a cleaner balance sheet and greater financial flexibility. The company's future hinges on its ability to leverage the growing global demand for sustainable textile fibers and eco-friendly packaging solutions. While its established expertise and niche market positioning offer a foundation for stable operations, it must navigate the inherent challenges of raw material price volatility, intense competition, and the relatively smaller scale of its current businesses to achieve sustained profitability and growth.
Price goes above X
Price falls below X
PE goes above X
PE falls below X
| #(Fig in Cr.) | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Net Sales | 60 | 66 | 70 | 67 | 59 | 65 | 67 | 61 | 55 | 65 |
| Other Income | 3 | 8 | 15 | 2 | 1 | 1 | 17 | 12 | 4 | 34 |
| Total Income | 63 | 75 | 85 | 69 | 60 | 66 | 84 | 73 | 59 | 99 |
| Total Expenditure | 76 | 75 | 81 | 76 | 70 | 72 | 93 | 72 | 74 | 81 |
| Operating Profit | -13 | -0 | 4 | -7 | -10 | -5 | -9 | 2 | -14 | 18 |
| Interest | 7 | 7 | 6 | 7 | 7 | 7 | 6 | 6 | 6 | 7 |
| Depreciation | 6 | 6 | 6 | 6 | 6 | 6 | 14 | 5 | 5 | 5 |
| Exceptional Income / Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -90 | 0 | 0 |
| Profit Before Tax | -27 | -14 | -8 | -20 | -24 | -18 | -29 | -99 | -26 | 6 |
| Provision for Tax | 0 | 0 | 4 | 26 | 0 | -0 | -7 | -0 | 0 | 0 |
| Profit After Tax | -27 | -14 | -12 | -46 | -24 | -18 | -22 | -99 | -26 | 6 |
| Adjustments | -32 | -36 | -228 | -16 | -46 | -51 | 5788 | 0 | 0 | 0 |
| Profit After Adjustments | -59 | -49 | -241 | -61 | -70 | -69 | 5766 | -99 | -26 | 6 |
| Adjusted Earnings Per Share | -1.9 | -1.6 | -7.7 | -2 | -2.3 | -2.2 | 185.6 | -3.2 | -0.8 | 0.2 |
| #(Fig in Cr.) | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|
| Net Sales | 3842 | 3873 | 2904 | 2646 | 2653 | 3606 | 3778 | 246 | 259 | 248 |
| Other Income | 63 | 159 | 61 | 40 | 72 | 37 | 70 | 28 | 21 | 67 |
| Total Income | 3904 | 4033 | 2965 | 2686 | 2725 | 3642 | 3848 | 274 | 279 | 315 |
| Total Expenditure | 3846 | 3947 | 2613 | 2417 | 2278 | 3094 | 3507 | 298 | 310 | 320 |
| Operating Profit | 58 | 86 | 352 | 269 | 448 | 549 | 341 | -24 | -31 | -3 |
| Interest | 283 | 443 | 357 | 344 | 276 | 502 | 450 | 27 | 28 | 25 |
| Depreciation | 136 | 146 | 108 | 113 | 118 | 112 | 103 | 25 | 32 | 29 |
| Exceptional Income / Expenses | 112 | -76 | 0 | 0 | -221 | -22 | -173 | 0 | 0 | -90 |
| Profit Before Tax | -250 | -580 | -112 | -188 | -167 | -87 | -385 | -76 | -91 | -148 |
| Provision for Tax | -8 | -2 | -12 | 0 | -307 | -10 | -191 | 4 | 19 | -7 |
| Profit After Tax | -242 | -578 | -100 | -188 | 140 | -77 | -194 | -80 | -110 | -141 |
| Adjustments | 0 | 0 | -263 | 0 | 0 | 0 | 0 | -301 | 5676 | 5788 |
| Profit After Adjustments | -242 | -578 | -363 | -188 | 140 | -77 | -194 | -381 | 5565 | 5647 |
| Adjusted Earnings Per Share | -17.7 | -36 | -21.8 | -11.3 | 7.3 | -3.2 | -6.3 | -12.3 | 179.1 | 181.8 |
| # | 1 Year | 3 Year | 5 Year | 10 Year |
|---|---|---|---|---|
| Sales CAGR | 5% | -58% | -37% | 0% |
| Operating Profit CAGR | 0% | NAN% | NAN% | 0% |
| PAT CAGR | 0% | 0% | 0% | 0% |
| # | 1 Year | 3 Year | 5 Year | 10 Year |
|---|---|---|---|---|
| Share Price CAGR | 155% | -41% | -28% | -18% |
| ROE Average | -40% | -36% | 30% | -278% |
| ROCE Average | -4% | -1% | 4% | 3% |
| #(Fig in Cr.) | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|
| Shareholder's Funds | 798 | 527 | 112 | -97 | 197 | 511 | 473 | 95 | 452 |
| Minority's Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Borrowings | 2137 | 2739 | 2143 | 1414 | 1941 | 1733 | 1810 | 2111 | 152 |
| Other Non-Current Liabilities | 260 | 286 | 264 | 113 | -153 | -155 | -348 | -239 | 4 |
| Total Current Liabilities | 2138 | 2565 | 2451 | 1782 | 985 | 1072 | 1038 | 1058 | 205 |
| Total Liabilities | 5333 | 6117 | 4970 | 3212 | 2970 | 3161 | 2973 | 3024 | 813 |
| Fixed Assets | 2544 | 2890 | 2772 | 2167 | 2081 | 2005 | 1736 | 1728 | 602 |
| Other Non-Current Assets | 1263 | 1683 | 1001 | 534 | 130 | 160 | 183 | 152 | 72 |
| Total Current Assets | 1526 | 1544 | 1197 | 511 | 759 | 996 | 994 | 1144 | 139 |
| Total Assets | 5333 | 6117 | 4970 | 3212 | 2970 | 3161 | 2973 | 3024 | 813 |
| #(Fig in Cr.) | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|
| Opening Cash & Cash Equivalents | 352 | 153 | 76 | 19 | 10 | 86 | 122 | 24 | 18 |
| Cash Flow from Operating Activities | 79 | 177 | 775 | 787 | 259 | 324 | 131 | -77 | 37 |
| Cash Flow from Investing Activities | 1792 | -992 | 575 | -445 | -150 | -63 | 49 | 75 | 7 |
| Cash Flow from Financing Activities | -2117 | 662 | -1823 | -218 | 201 | -224 | -248 | -4 | -49 |
| Net Cash Inflow / Outflow | -246 | -153 | -473 | 123 | 309 | 36 | -68 | -6 | -5 |
| Closing Cash & Cash Equivalent | 8 | -145 | -617 | -290 | 86 | 122 | 54 | 18 | 13 |
| # | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|
| Earnings Per Share (Rs) | -17.66 | -35.98 | -21.8 | -11.25 | 7.27 | -3.16 | -6.25 | -12.28 | 179.14 |
| CEPS(Rs) | -7.72 | -26.88 | 0.45 | -4.5 | 13.4 | 1.41 | -2.95 | -1.77 | -2.52 |
| DPS(Rs) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Book NAV/Share(Rs) | 58.2 | 27.71 | 6.74 | -5.84 | 10.25 | 20.85 | 15.23 | 3.05 | 14.53 |
| Core EBITDA Margin(%) | -0.11 | -1.85 | 10.03 | 8.63 | 14.15 | 14.2 | 6.58 | -19.53 | -18.56 |
| EBIT Margin(%) | 0.77 | -3.42 | 8.41 | 5.9 | 4.1 | 11.49 | 1.59 | -18.33 | -22.71 |
| Pre Tax Margin(%) | -5.78 | -14.5 | -3.87 | -7.09 | -6.29 | -2.42 | -9.36 | -28.39 | -32.71 |
| PAT Margin (%) | -5.6 | -14.45 | -3.46 | -7.09 | 5.28 | -2.14 | -4.72 | -30.05 | -39.69 |
| Cash Profit Margin (%) | -2.45 | -10.8 | 0.26 | -2.83 | 9.73 | 0.95 | -2.23 | -20.72 | -28.15 |
| ROA(%) | -5.01 | -10.09 | -1.81 | -4.58 | 4.53 | -2.52 | -6.33 | -2.67 | -5.76 |
| ROE(%) | -22.8 | -92.97 | -36.06 | -2498.73 | 279.58 | -21.88 | -39.54 | -28.15 | -40.44 |
| ROCE(%) | 0.89 | -3.13 | 6.16 | 5.77 | 5.03 | 17.94 | 2.71 | -2.05 | -4.2 |
| Receivable days | 38.26 | 50.22 | 72.88 | 54.06 | 34.52 | 31.64 | 30.73 | 576.39 | 328.13 |
| Inventory Days | 44.54 | 42.23 | 50.88 | 35.44 | 20.6 | 16.08 | 18.31 | 355.8 | 211.78 |
| Payable days | 88.4 | 138.89 | 583 | 616.89 | 575.06 | 565.53 | 481.16 | 2049.87 | 1003.4 |
| PER(x) | 0 | 0 | 0 | 0 | 8.25 | 0 | 0 | 0 | 0.03 |
| Price/Book(x) | 2.11 | 3.36 | 9.24 | -2.7 | 5.85 | 2.51 | 3.85 | 56.11 | 0.31 |
| Dividend Yield(%) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EV/Net Sales(x) | 1.25 | 1.42 | 1.44 | 0.93 | 1.15 | 0.83 | 0.96 | 30.05 | 1.25 |
| EV/Core EBITDA(x) | 82.67 | 64.15 | 11.86 | 9.15 | 6.84 | 5.46 | 10.69 | -309.25 | -10.41 |
| Net Sales Growth(%) | -0.93 | 0.82 | -25.02 | -8.89 | 0.27 | 35.93 | 4.77 | -93.48 | 5.02 |
| EBIT Growth(%) | -93.68 | -507.37 | 278.83 | -36.06 | -30.26 | 280.75 | -84.26 | -174.77 | -29.61 |
| PAT Growth(%) | -163.92 | -138.57 | 82.61 | -86.71 | 174.71 | -155.2 | -151.19 | 58.85 | -38.17 |
| EPS Growth(%) | -131.55 | -103.71 | 39.41 | 48.38 | 164.64 | -143.51 | -97.62 | -96.31 | 1559.22 |
| Debt/Equity(x) | 4.13 | 9.22 | 28.39 | -22.76 | 10.22 | 3.72 | 4.09 | 23.91 | 0.44 |
| Current Ratio(x) | 0.71 | 0.6 | 0.49 | 0.29 | 0.77 | 0.93 | 0.96 | 1.08 | 0.68 |
| Quick Ratio(x) | 0.5 | 0.42 | 0.34 | 0.2 | 0.63 | 0.76 | 0.73 | 0.81 | 0.5 |
| Interest Cover(x) | 0.12 | -0.31 | 0.68 | 0.45 | 0.39 | 0.83 | 0.14 | -1.82 | -2.27 |
| Total Debt/Mcap(x) | 1.96 | 2.74 | 3.07 | 8.44 | 1.75 | 1.48 | 1.06 | 0.43 | 1.42 |
| # | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Promoter | 43.4 | 43.34 | 43.34 | 43.34 | 43.34 | 43.34 | 43.34 | 43.34 | 43.34 | 43.34 |
| FII | 7.18 | 8.95 | 8.43 | 7.17 | 5.03 | 2.73 | 0.78 | 0.77 | 0.19 | 0 |
| DII | 13.41 | 12.89 | 16.37 | 17.4 | 16 | 15.87 | 8.1 | 9.58 | 3.97 | 3.97 |
| Public | 33.75 | 32.55 | 29.6 | 29.83 | 33.36 | 35.79 | 45.5 | 46.31 | 50.23 | 50.42 |
| Others | 2.27 | 2.27 | 2.27 | 2.27 | 2.27 | 2.27 | 2.27 | 0 | 2.27 | 2.27 |
| Total | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 |
| # | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Promoter | 13.48 | 13.47 | 13.47 | 13.47 | 13.47 | 13.47 | 13.47 | 13.47 | 13.47 | 13.47 |
| FII | 2.23 | 2.78 | 2.62 | 2.23 | 1.56 | 0.85 | 0.24 | 0.24 | 0.06 | 0 |
| DII | 4.17 | 4 | 5.08 | 5.4 | 4.97 | 4.93 | 2.52 | 2.98 | 1.23 | 1.23 |
| Public | 10.48 | 10.11 | 9.19 | 9.27 | 10.36 | 11.12 | 14.14 | 14.39 | 15.6 | 15.66 |
| Others | 0.7 | 0.7 | 0.7 | 0.7 | 0.7 | 0.7 | 0.7 | 0 | 0.7 | 0.7 |
| Total | 31.07 | 31.07 | 31.07 | 31.07 | 31.07 | 31.07 | 31.07 | 31.07 | 31.07 | 31.07 |
| # | 1 Year | 3 Year | 5 Year | 10 Year |
|---|---|---|---|---|
| Sales CAGR | +5% | -58% | -37% | — |
| Operating Profit CAGR | — | 0% | 0% | — |
| PAT CAGR | — | — | — | — |
| Share Price CAGR | +155% | -41% | -28% | -18% |
| ROE Average | -40% | -36% | +30% | -278% |
| ROCE Average | -4% | -1% | +4% | +3% |
| # | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Promoter | 43.4 | 43.34 | 43.34 | 43.34 | 43.34 | 43.34 | 43.34 | 43.34 | 43.34 | 43.34 |
| FII | 7.18 | 8.95 | 8.43 | 7.17 | 5.03 | 2.73 | 0.78 | 0.77 | 0.19 | 0 |
| DII | 13.41 | 12.89 | 16.37 | 17.4 | 16 | 15.87 | 8.1 | 9.58 | 3.97 | 3.97 |
| Public | 54.34 | 54.39 | 54.39 | 54.39 | 54.39 | 54.39 | 54.39 | 56.66 | 54.39 | 54.39 |
| Others | 2.27 | 2.27 | 2.27 | 2.27 | 2.27 | 2.27 | 2.27 | 0 | 2.27 | 2.27 |
| Total | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 |
| # | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Promoter | 13.48 | 13.47 | 13.47 | 13.47 | 13.47 | 13.47 | 13.47 | 13.47 | 13.47 | 13.47 |
| FII | 2.23 | 2.78 | 2.62 | 2.23 | 1.56 | 0.85 | 0.24 | 0.24 | 0.06 | 0 |
| DII | 4.17 | 4 | 5.08 | 5.4 | 4.97 | 4.93 | 2.52 | 2.98 | 1.23 | 1.23 |
| Public | 16.88 | 16.9 | 16.9 | 16.9 | 16.9 | 16.9 | 16.9 | 17.6 | 16.9 | 16.9 |
| Others | 0.7 | 0.7 | 0.7 | 0.7 | 0.7 | 0.7 | 0.7 | 0 | 0.7 | 0.7 |
| Total | 31.07 | 31.07 | 31.07 | 31.07 | 31.07 | 31.07 | 31.07 | 31.07 | 31.07 | 31.07 |
* The pros and cons are machine generated.
Our experts help you choose the right stocks based on performance, risk, and growth potential.
Looking to buy unlisted shares or need guidance on the investment process? Our expert Private Equity Advisors are here to assist you with accurate information, real-time pricing, and seamless execution.
Want to sell unlisted shares, liquidate your ESOPs, or understand the step-by-step process of liquidation? Connect with our Buying Team for smooth coordination, quick evaluations, and end-to-end support.
Planning to build or grow your portfolio? For Mutual Fund investments, PMS solutions, tailored portfolio creation, and overall wealth management, our dedicated Wealth Team is ready to guide you.